• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类头颈癌的体外放射敏感性

The in vitro radiosensitivity of human head and neck cancers.

作者信息

Björk-Eriksson T, West C M, Karlsson E, Slevin N J, Davidson S E, James R D, Mercke C

机构信息

Department of Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden.

出版信息

Br J Cancer. 1998 Jun;77(12):2371-5. doi: 10.1038/bjc.1998.394.

DOI:10.1038/bjc.1998.394
PMID:9649161
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2150420/
Abstract

A study was made of the intrinsic radiosensitivity of 140 biopsy and surgical specimens of malignant head and neck tumours of different histologies. Using a soft-agar clonogenic assay, the material was assessed for the ability to grow in culture (colony-forming efficiency; CFE) and inherent tumour radiosensitivity (surviving fraction at 2 Gy, SF2). The success rate for obtaining growth was 74% (104/140) with a mean CFE of 0.093% (median 0.031) and a range of 0.002-1.3%. SF2 was obtained for 88 of 140 specimens, representing a success rate of 63% with a mean SF2 of 0.48 (median 0.43) and a range of 0.10-1.00. There were no significant differences in radiosensitivity between different sites of the head and neck region. There were no significant relationships between SF2 and disease stage, nodal status, tumour grade, patient age, primary tumour growth pattern and CFE. The results were compared with those for other tumour types previously analysed with the same assay. The distribution of the SF2 values for the head and neck tumours was similar to that for 145 cervix carcinomas and there was no significant difference in mean radiosensitivity between the two tumour types. Also, there was no significant difference in radiosensitivity between head and neck tumours and either breast or colorectal cancers. However, a group of eight lymphomas was significantly more radiosensitive. These results confirm the feasibility of carrying out radiosensitivity measurements using a soft-agar clonogenic assay on head and neck tumours. In addition, the work has shown that radiosensitivity is independent of many clinical parameters and that the mean value is similar to that reported for cervix carcinomas.

摘要

对140份不同组织学类型的头颈部恶性肿瘤活检和手术标本的内在放射敏感性进行了研究。采用软琼脂克隆形成试验,评估该材料在培养中的生长能力(集落形成效率;CFE)和内在肿瘤放射敏感性(2 Gy时的存活分数,SF2)。获得生长的成功率为74%(104/140),平均CFE为0.093%(中位数0.031),范围为0.002 - 1.3%。140份标本中有88份获得了SF2,成功率为63%,平均SF2为0.48(中位数0.43),范围为0.10 - 1.00。头颈部不同部位之间的放射敏感性无显著差异。SF2与疾病分期、淋巴结状态、肿瘤分级、患者年龄、原发肿瘤生长模式和CFE之间均无显著相关性。将结果与之前用相同试验分析的其他肿瘤类型的结果进行了比较。头颈部肿瘤的SF2值分布与145例宫颈癌相似,两种肿瘤类型的平均放射敏感性无显著差异。此外,头颈部肿瘤与乳腺癌或结直肠癌之间的放射敏感性也无显著差异。然而,一组8例淋巴瘤的放射敏感性明显更高。这些结果证实了对头颈部肿瘤使用软琼脂克隆形成试验进行放射敏感性测量的可行性。此外,这项工作表明放射敏感性与许多临床参数无关,且平均值与宫颈癌报道的相似。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9944/2150420/cecbadd15ebd/brjcancer00088-0318-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9944/2150420/cecbadd15ebd/brjcancer00088-0318-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9944/2150420/cecbadd15ebd/brjcancer00088-0318-a.jpg

相似文献

1
The in vitro radiosensitivity of human head and neck cancers.人类头颈癌的体外放射敏感性
Br J Cancer. 1998 Jun;77(12):2371-5. doi: 10.1038/bjc.1998.394.
2
Relationship between tumour cell in vitro radiosensitivity and clinical outcome after curative radiotherapy for squamous cell carcinoma of the head and neck.头颈部鳞状细胞癌根治性放疗后肿瘤细胞体外放射敏感性与临床结局的关系
Radiother Oncol. 1999 Jan;50(1):47-55. doi: 10.1016/s0167-8140(98)00129-7.
3
Tumor radiosensitivity (SF2) is a prognostic factor for local control in head and neck cancers.肿瘤放射敏感性(SF2)是头颈部癌症局部控制的一个预后因素。
Int J Radiat Oncol Biol Phys. 2000 Jan 1;46(1):13-9. doi: 10.1016/s0360-3016(99)00373-9.
4
In vitro radiosensitivity of tumour cells and fibroblasts derived from head and neck carcinomas: mutual relationship and correlation with clinical data.头颈部癌来源的肿瘤细胞和成纤维细胞的体外放射敏感性:相互关系及与临床数据的相关性
Br J Cancer. 1999 Mar;79(7-8):1074-84. doi: 10.1038/sj.bjc.6690172.
5
Selective assessment of in vitro radiosensitivity of tumour cells and fibroblasts from single tumour biopsies using immunocytochemical identification of colonies in the soft agar clonogenic assay.在软琼脂克隆形成试验中,通过对集落进行免疫细胞化学鉴定,对来自单个肿瘤活检组织的肿瘤细胞和成纤维细胞的体外放射敏感性进行选择性评估。
Radiother Oncol. 1995 Nov;37(2):87-99. doi: 10.1016/0167-8140(95)98589-d.
6
The lack of correlation between proliferation (Ki-67, PCNA, LI, Tpot), p53 expression and radiosensitivity for head and neck cancers.头颈部癌症的增殖(Ki-67、PCNA、LI、Tpot)、p53表达与放射敏感性之间缺乏相关性。
Br J Cancer. 1999 Jul;80(9):1400-4. doi: 10.1038/sj.bjc.6690535.
7
Radiosensitivity of dermal and tumor fibroblasts derived from the same patient.源自同一患者的皮肤和肿瘤成纤维细胞的放射敏感性。
J Cancer Res Clin Oncol. 1998;124(8):415-20. doi: 10.1007/s004320050193.
8
Radiosensitivity testing of primary cervical carcinoma: evaluation of intra- and inter-tumour heterogeneity.原发性宫颈癌的放射敏感性检测:肿瘤内及肿瘤间异质性评估
Radiother Oncol. 1990 Aug;18(4):349-56. doi: 10.1016/0167-8140(90)90115-d.
9
Does skin fibroblast radiosensitivity predict squamous cancer cell radiosensitivity of the same individual?皮肤成纤维细胞放射敏感性能否预测同一个体的鳞状癌细胞放射敏感性?
Int J Cancer. 2003 Mar 1;103(6):784-8. doi: 10.1002/ijc.10890.
10
The immunohistochemical expression of DNA-PKCS and Ku (p70/p80) in head and neck cancers: relationships with radiosensitivity.DNA依赖蛋白激酶催化亚基(DNA-PKCS)和Ku(p70/p80)在头颈癌中的免疫组化表达:与放射敏感性的关系
Int J Radiat Oncol Biol Phys. 1999 Nov 1;45(4):1005-10. doi: 10.1016/s0360-3016(99)00268-0.

引用本文的文献

1
Dynamic Characteristics and Predictive Capability of Tumor Voxel Dose-Response Assessed Using F-FDG PET/CT Imaging Feedback.使用F-FDG PET/CT成像反馈评估肿瘤体素剂量反应的动态特征和预测能力。
Front Oncol. 2022 Jul 6;12:876861. doi: 10.3389/fonc.2022.876861. eCollection 2022.
2
Feasibility of Primary Tumor Culture Models and Preclinical Prediction Assays for Head and Neck Cancer: A Narrative Review.头颈部癌原发性肿瘤培养模型及临床前预测分析的可行性:一项叙述性综述
Cancers (Basel). 2015 Aug 28;7(3):1716-42. doi: 10.3390/cancers7030858.
3
Abrogation of radioresistance in glioblastoma stem-like cells by inhibition of ATM kinase.

本文引用的文献

1
Selective assessment of in vitro radiosensitivity of tumour cells and fibroblasts from single tumour biopsies using immunocytochemical identification of colonies in the soft agar clonogenic assay.在软琼脂克隆形成试验中,通过对集落进行免疫细胞化学鉴定,对来自单个肿瘤活检组织的肿瘤细胞和成纤维细胞的体外放射敏感性进行选择性评估。
Radiother Oncol. 1995 Nov;37(2):87-99. doi: 10.1016/0167-8140(95)98589-d.
2
DNA double-strand break rejoining rates, inherent radiation sensitivity and human tumour response to radiotherapy.DNA双链断裂重新连接率、内在辐射敏感性与人类肿瘤对放疗的反应
Br J Cancer. 1996 Jul;74(1):37-42. doi: 10.1038/bjc.1996.312.
3
通过抑制 ATM 激酶消除胶质母细胞瘤干细胞样细胞中的放射抗性。
Mol Oncol. 2015 Jan;9(1):192-203. doi: 10.1016/j.molonc.2014.08.003. Epub 2014 Aug 24.
4
Predictive value of modelled tumour control probability based on individual measurements of in vitro radiosensitivity and potential doubling time.基于体外放射敏感性和潜在倍增时间的个体测量预测肿瘤控制概率。
Br J Radiol. 2013 May;86(1025):20130015. doi: 10.1259/bjr.20130015. Epub 2013 Mar 11.
5
Clinically relevant biomarkers in targeted radiotherapy.靶向放射治疗中的临床相关生物标志物。
Clin Exp Metastasis. 2012 Oct;29(7):853-60. doi: 10.1007/s10585-012-9523-z. Epub 2012 Aug 11.
6
The lack of correlation between proliferation (Ki-67, PCNA, LI, Tpot), p53 expression and radiosensitivity for head and neck cancers.头颈部癌症的增殖(Ki-67、PCNA、LI、Tpot)、p53表达与放射敏感性之间缺乏相关性。
Br J Cancer. 1999 Jul;80(9):1400-4. doi: 10.1038/sj.bjc.6690535.
Predictive value of in vitro radiosensitivity parameters in head and neck cancers and cervical carcinomas: preliminary correlations with local control and overall survival.
头颈部癌和宫颈癌体外放射敏感性参数的预测价值:与局部控制和总生存的初步相关性
Int J Radiat Oncol Biol Phys. 1993 Jan;25(1):3-7. doi: 10.1016/0360-3016(93)90137-k.
4
Intrinsic radiosensitivity and prediction of patient response to radiotherapy for carcinoma of the cervix.子宫颈癌的内在放射敏感性及患者对放疗反应的预测
Br J Cancer. 1993 Oct;68(4):819-23. doi: 10.1038/bjc.1993.434.
5
Primary site as predictive factor of local control in advanced head and neck tumors treated by concomitant boost accelerated radiotherapy.在同步加量加速放疗治疗的晚期头颈部肿瘤中,原发部位作为局部控制的预测因素。
Tumori. 1994 Apr 30;80(2):135-8. doi: 10.1177/030089169408000210.
6
In vitro parameters and treatment outcome in head and neck cancers treated with surgery and/or radiation: cell characterization and correlations with local control and overall survival.接受手术和/或放疗的头颈癌的体外参数与治疗结果:细胞特征及其与局部控制和总生存期的相关性
Int J Radiat Oncol Biol Phys. 1994 Nov 15;30(4):789-94. doi: 10.1016/0360-3016(94)90350-6.
7
Use of fluorescence in situ hybridization to measure chromosome aberrations as a predictor of radiosensitivity in human tumour cells.使用荧光原位杂交技术测量染色体畸变,以此作为人类肿瘤细胞放射敏感性的预测指标。
Int J Radiat Biol. 1994 Sep;66(3):297-307. doi: 10.1080/09553009414551231.
8
DNA double-strand break repair and radiation response in human tumour primary cultures.人类肿瘤原代培养物中的DNA双链断裂修复与辐射反应
Int J Radiat Biol. 1994 Sep;66(3):279-85. doi: 10.1080/09553009414551211.
9
Comparison of cellular radiosensitivity between different localizations of head and neck squamous-cell carcinoma.头颈部鳞状细胞癌不同部位之间细胞放射敏感性的比较。
J Cancer Res Clin Oncol. 1995;121(8):452-6. doi: 10.1007/BF01218360.
10
Invited review: intrinsic radiosensitivity as a predictor of patient response to radiotherapy.特邀综述:固有放射敏感性作为患者放疗反应的预测指标
Br J Radiol. 1995 Aug;68(812):827-37. doi: 10.1259/0007-1285-68-812-827.